Application 219271
- Type
- ANDA
- Sponsor
- HETERO LABS LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | INJECTION;SOLUTION | 500MG/2.5ML | No | No |
| 003 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | INJECTION;SOLUTION | 2000MG/10ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclophosphamide | CYCLOPHOSPHAMIDE FOR INJECTION | Hainan Poly Pharm. Co., Ltd. | 6fde2705-a2d8-4d48-9618-b9d99d051373 | 2025-01-03 | Warnings, Adverse reactions | Cyclophosphamide |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Sandoz Inc | cf2f4b95-0327-499a-a5a3-51b1bdef68c5 | 2024-12-30 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | XGen Pharmaceuticals DJB, Inc. | 02e64046-687d-449e-e063-6294a90a6c32 | 2024-12-20 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Alembic Pharmaceuticals Limited | 9e699cf7-860e-4c03-9760-0c24d56df2de | 2024-12-16 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Alembic Pharmaceuticals Inc. | 3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1 | 2024-12-10 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | NorthStar Rx LLC | 76f057be-e3da-0a89-e053-2a91aa0a8438 | 2024-11-20 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Hikma Pharmaceuticals USA Inc. | 8135b917-882f-4b4c-99b7-fa8ea54af4bf | 2024-11-19 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Fresenius Kabi USA, LLC | 31986d36-a1bf-4903-93a4-ce7386241ba1 | 2024-10-09 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Avyxa Pharma, LLC | 6f593585-e0dd-48bc-bd2b-c6c787e0b98c | 2024-07-26 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | Baxter Healthcare Company | 34dbffee-80e0-49c3-90e8-95713a0b7fbe | 2024-04-10 | Warnings, Adverse reactions | Cyclophosphamide |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Baxter Healthcare Corporation | 769ded74-6186-40a8-8e44-ceff67287451 | 2020-08-07 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | Baxter Healthcare Company | cef038cc-efab-46d9-99c2-95bb11d6c9bc | 2017-03-15 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | Baxter Healthcare Company | 6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe | 2017-03-15 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.